Currently Viewing:

AJMC® in the Press, June 19, 2020

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A piece by 3rd Watch News referenced an article published on, the website of The American Journal of Managed Care® (AJMC®). The article, “Diabetic Amputations May Be Rising in the United States,” highlights that lower-limb amputations may be rising in the United States after decades of decline, with approximately 230 reported amputations attributed to diabetes in the United States.

An article by Health Payer Intelligence cited a study published in the June 2020 issue of AJMC®, titled “Value-Based Insurance Design in Louisiana: Blue Cross Blue Shield’s Zero Dollar Co-pay Program.” The study indicated that enrollment in a value-based insurance design program that eliminated pharmacy co-pays for 4 chronic disease drug classes was associated with a large decline in health care spending.

Medical Xpress’ article, “Effect of high-deductible insurance use in bipolar disorder,” referenced a study published in the June 2020 issue of AJMC®. The study, “Effect of High-Deductible Insurance on Health Care Use in Bipolar Disorder,” found that high-deductible health plan members with bipolar disorder experienced a reduction in nonpsychiatrist mental health provider visits but no changes in other utilization.

MedCity News mentioned a study published in the March 2019 issue of AJMC®’s sister journal, Evidence-Based Diabetes Management™. The study, “A New Era: Increasing Continuous Glucose Monitoring Use in Type 2 Diabetes,” found that continuous glucose monitors are increasingly accessible and effective for patients with type 2 diabetes, and even those with prediabetes, as a means for real-time biofeedback and behavior change.

Related Articles

Value-Based Insurance Design in Louisiana: Blue Cross Blue Shield’s Zero Dollar Co-pay Program
Dr Robert Gabbay on Diabetes in the COVID-19 Era
Could the COVID-19 Pandemic Create New Opportunities for the Adoption of APMs and Be a Catalyst for the Movement From Volume to Value?
Cardiovascular Benefits of Vascepa Greater for Those With Diabetes, New REDUCE-IT Data Show
Beneficiaries Face Limited Access to Medicare Diabetes Prevention Program
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up